AzTrials
AzTrials

Egg Donor Recipient CharacteristicsNCT01219491

Egg Donor Recipient Characteristics Preferences

An observational study of Egg Donor Recipient Characteristics, run by Reproductive Medicine Associates of New Jersey at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To identify the characteristics in an egg donor that are important to a recipient and to see if those characteristics change over time. Read more about this study

Who is it for?
Ages 21 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Egg Donor Recipient Characteristics
How many people
131 participants
Where
3 sitesUnited States
Study dates
Dec 2007to Nov 2011
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Patients who are planning to undergo an egg donor cycle are eligible

All patients planning to undergo an egg donor cycle are eligible- there are no specific inclusion or exclusion criteria beyond that.

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • Reproductive Medicine Assoicates of New Jersey

    Morristown, New Jersey, 07960

  • Reproductive Medicine Associates of New York

    New York, New York, 10022

  • Reproductive Medicine Associates of Connecticut

    Norwalk, Connecticut, 06850

Other trials in United States

About this study

Official title: Do Egg Donor Recipient Characteristics Change Over Time?

To identify the characteristics in an egg donor that are important to a recipient and to see if those characteristics change over time.

Read the detailed description

No study has explored how recipients' attitudes and reactions change over time regarding the selection criteria for their donors. Consequently, programs have no guidance in how to counsel prospective recipients as to whether their donor preferences will change over time. Participants will complete a survey at 4 points in time as they go through the process of selecting an egg donor and pursuing a pregnancy using that egg donor.

Keywords
egg donor, recipients, donor characteristics

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01219491
Study groupRoleWhat they receive
Egg donor recipientsNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Characteristics of Donors

    To identify the characteristics of donors which are important to recipients and whether their importance changes over time.

    Measured: duration of study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Oct 2010 (estimated)
  2. Study startDec 2007
  3. Primary completionNov 2011
  4. Study completionNov 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Prospective
Enrolment
131 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01219491
Sponsor's protocol ID
RMA-00-16
Status last verified
Mar 2013
First submitted
8 Oct 2010
Last updated
5 Mar 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Egg Donor Recipient Characteristics, run by Reproductive Medicine Associates of New Jersey at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Mar 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Characteristics of Donors (time frame: duration of study). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in